LNSR Earnings

LNSR reported its FY2024Q4 earnings on 2025-02-27, showcasing a revenue of 16.73M against an estimate of 14.95M, resulting in a 11.91% surprise. The EPS was -1.61, surpassing the expected -0.18 by -794.44%. The stock experienced a 14.78% price change on the earnings day and a 61.99% change over the next five days, reflecting market reactions to the results.

Following LNSR's FY2024Q4 earnings announcement on 2025-02-27, the stock price moved by 14.78% on the day of the release. Over the subsequent five days, it saw a 61.99% change. Historically, LNSR's stock price tends to shift by an average of -1.4% in the 10 days leading up to earnings and 2.57% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate LNSR's annual revenue to reach 19.00M, while the EPS is projected at -0.09. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between LNSR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LNSR's stock price typically moves by -1.4% in the 10 days before its earnings and 2.57% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.09 and revenue of 19.00M.

Despite a decline in Q4 revenue, the company showcased strong recurring revenue and procedure volume growth, indicating a solid customer base and utilization. However, international sales were negatively impacted by distributor uncertainty, and gross margins slightly declined. The Q&A revealed challenges in rebuilding international momentum and an expected increase in operating expenses. Overall, the mixed signals from financial performance and market strategy suggest a neutral sentiment, with potential for improvement if international sales recover and cost management is effective.